Stay updated on Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page.

Latest updates to the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page
- Check2 days agoChange DetectedA general NIH notice about the terminology transition appears above the 403 error page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, removing the detailed study information from view. The error page includes the site header and a restricted-access message.SummaryDifference19%

- Check37 days agoChange DetectedThe page shows revision v3.7.0, indicating a new release or update to the record. This update does not alter the study details or clinical information presented.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, reflecting a recent update to the record's metadata. This appears to be a maintenance update rather than a change to the study data or its results.SummaryDifference0.1%

- Check73 days agoChange DetectedThe revision label on the page was updated from v3.6.4 to v3.6.5, signaling a newer page revision. This update appears to be a system-level change rather than a modification to the study details.SummaryDifference0.1%

Stay in the know with updates to Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page.